Skip to main content
. Author manuscript; available in PMC: 2011 Mar 1.
Published in final edited form as: Cancer Res. 2010 Feb 16;70(5):1916–1924. doi: 10.1158/0008-5472.CAN-09-3993

Figure 3.

Figure 3

Validation of prognostic potential of hsa-miR-29c* using qRT-PCR (A) left panel reveals microarray expression values for hsa-mir-29c* in 16 mesotheliomas compared to expression measured by qRT-PCR (right panel). In both cases, elevated hsa-mir-29c* was associated with good prognosis. (B) qRT-PCR for hsa-mir-29c* separating the validation individuals significantly by their survival at a cut-off comparable to the consistent cutoff used for the microarray data.